These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 19789652)
1. Skin electroporation: effects on transgene expression, DNA persistence and local tissue environment. Roos AK; Eriksson F; Timmons JA; Gerhardt J; Nyman U; Gudmundsdotter L; Bråve A; Wahren B; Pisa P PLoS One; 2009 Sep; 4(9):e7226. PubMed ID: 19789652 [TBL] [Abstract][Full Text] [Related]
2. Biodistribution, persistence and lack of integration of a multigene HIV vaccine delivered by needle-free intradermal injection and electroporation. Bråve A; Gudmundsdotter L; Sandström E; Haller BK; Hallengärd D; Maltais AK; King AD; Stout RR; Blomberg P; Höglund U; Hejdeman B; Biberfeld G; Wahren B Vaccine; 2010 Nov; 28(51):8203-9. PubMed ID: 20951666 [TBL] [Abstract][Full Text] [Related]
3. Optimization of electroporation-enhanced intradermal delivery of DNA vaccine using a minimally invasive surface device. Lin F; Shen X; Kichaev G; Mendoza JM; Yang M; Armendi P; Yan J; Kobinger GP; Bello A; Khan AS; Broderick KE; Sardesai NY Hum Gene Ther Methods; 2012 Jun; 23(3):157-68. PubMed ID: 22794496 [TBL] [Abstract][Full Text] [Related]
4. Immunogenicity and Biodistribution of Anthrax DNA Vaccine Delivered by Intradermal Electroporation. Kim NY; Son WR; Choi JY; Yu CH; Hur GH; Jeong ST; Shin YK; Hong SY; Shin S Curr Drug Deliv; 2020; 17(5):414-421. PubMed ID: 32286944 [TBL] [Abstract][Full Text] [Related]
5. Enhancement of cellular immune response to a prostate cancer DNA vaccine by intradermal electroporation. Roos AK; Moreno S; Leder C; Pavlenko M; King A; Pisa P Mol Ther; 2006 Feb; 13(2):320-7. PubMed ID: 16185933 [TBL] [Abstract][Full Text] [Related]
6. Intradermal delivery of interleukin-12 plasmid DNA by in vivo electroporation. Heller R; Schultz J; Lucas ML; Jaroszeski MJ; Heller LC; Gilbert RA; Moelling K; Nicolau C DNA Cell Biol; 2001 Jan; 20(1):21-6. PubMed ID: 11242540 [TBL] [Abstract][Full Text] [Related]
7. Cutaneous transfection and immune responses to intradermal nucleic acid vaccination are significantly enhanced by in vivo electropermeabilization. Drabick JJ; Glasspool-Malone J; King A; Malone RW Mol Ther; 2001 Feb; 3(2):249-55. PubMed ID: 11237682 [TBL] [Abstract][Full Text] [Related]
9. DNA vaccination for prostate cancer. Roos AK; King A; Pisa P Methods Mol Biol; 2008; 423():463-72. PubMed ID: 18370222 [TBL] [Abstract][Full Text] [Related]
10. A multi-head intradermal electroporation device allows for tailored and increased dose DNA vaccine delivery to the skin. McCoy JR; Mendoza JM; Spik KW; Badger C; Gomez AF; Schmaljohn CS; Sardesai NY; Broderick KE Hum Vaccin Immunother; 2014; 10(10):3039-47. PubMed ID: 25483486 [TBL] [Abstract][Full Text] [Related]
11. Optimization of skin electroporation in mice to increase tolerability of DNA vaccine delivery to patients. Roos AK; Eriksson F; Walters DC; Pisa P; King AD Mol Ther; 2009 Sep; 17(9):1637-42. PubMed ID: 19532140 [TBL] [Abstract][Full Text] [Related]
12. Optimisation of intradermal DNA electrotransfer for immunisation. Vandermeulen G; Staes E; Vanderhaeghen ML; Bureau MF; Scherman D; Préat V J Control Release; 2007 Dec; 124(1-2):81-7. PubMed ID: 17854939 [TBL] [Abstract][Full Text] [Related]
13. Needle-free topical electroporation improves gene expression from plasmids administered in porcine skin. Babiuk S; Baca-Estrada ME; Foldvari M; Baizer L; Stout R; Storms M; Rabussay D; Widera G; Babiuk L Mol Ther; 2003 Dec; 8(6):992-8. PubMed ID: 14664802 [TBL] [Abstract][Full Text] [Related]
14. Injection site-dependent induction of immune response by DNA vaccine: comparison of skin and spleen as a target for vaccination. Guan X; Nishikawa M; Takemoto S; Ohno Y; Yata T; Takakura Y J Gene Med; 2010 Mar; 12(3):301-9. PubMed ID: 20084616 [TBL] [Abstract][Full Text] [Related]
15. Optimal salt concentration of vehicle for plasmid DNA enhances gene transfer mediated by electroporation. Lee MJ; Cho SS; Jang HS; Lim YS; You JR; Park J; Suh H; Kim JA; Park JS; Kim DK Exp Mol Med; 2002 Sep; 34(4):265-72. PubMed ID: 12515391 [TBL] [Abstract][Full Text] [Related]
16. Plasmid DNA gene therapy by electroporation: principles and recent advances. Murakami T; Sunada Y Curr Gene Ther; 2011 Dec; 11(6):447-56. PubMed ID: 22023474 [TBL] [Abstract][Full Text] [Related]
17. Late administration of plasmid DNA by intradermal electroporation efficiently boosts DNA-primed T and B cell responses to carcinoembryonic antigen. Bråve A; Hallengärd D; Gudmundsdotter L; Stout R; Walters R; Wahren B; Hallermalm K Vaccine; 2009 Jun; 27(28):3692-6. PubMed ID: 19428161 [TBL] [Abstract][Full Text] [Related]
18. Integration of needle-free jet injection with advanced electroporation delivery enhances the magnitude, kinetics, and persistence of engineered DNA vaccine induced immune responses. Jiang J; Ramos SJ; Bangalore P; Fisher P; Germar K; Lee BK; Williamson D; Kemme A; Schade E; McCoy J; Muthumani K; Weiner DB; Humeau LM; Broderick KE Vaccine; 2019 Jun; 37(29):3832-3839. PubMed ID: 31174938 [TBL] [Abstract][Full Text] [Related]
19. Microfluidic Electroporation Coupling Pulses of Nanoseconds and Milliseconds to Facilitate Rapid Uptake and Enhanced Expression of DNA in Cell Therapy. Chang AY; Liu X; Tian H; Hua L; Yang Z; Wang S Sci Rep; 2020 Apr; 10(1):6061. PubMed ID: 32269260 [TBL] [Abstract][Full Text] [Related]
20. DNA vaccination in skin enhanced by electroporation. Broderick KE; Khan AS; Sardesai NY Methods Mol Biol; 2014; 1143():123-30. PubMed ID: 24715285 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]